| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Caldwell Christopher A | President and CEO, Director | 39899 BALENTINE DRIVE, SUITE 235, NEWARK | /s/ Andrew A. Farwig, Attorney-in-Fact | 30 Jan 2026 | 0001604279 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CNXC | Common Stock | Award | $0 | +2,855 | +0.79% | $0.000000 | 362,285 | 28 Jan 2026 | Direct | F1 |
| transaction | CNXC | Common Stock | Tax liability | $43,947 | -1,210 | -0.33% | $36.32 | 361,075 | 28 Jan 2026 | Direct |
| Id | Content |
|---|---|
| F1 | Represents shares issued upon the vesting of restricted stock units awarded under the 2020 Stock Incentive Plan on January 27, 2023, subject to the satisfaction of performance metrics measured over a three-year period ending November 30, 2025. |